+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
RNA Therapy Market by Therapeutic Area (Cardiovascular Diseases, Genetic Disorders, Infectious Diseases), Delivery System (Exosomes, Lipid Nanoparticles, Polymer Carriers), End User - Global Forecast 2025-2030- Product Image
RNA Therapy Market by Therapeutic Area (Cardiovascular Diseases, Genetic Disorders, Infectious Diseases), Delivery System (Exosomes, Lipid Nanoparticles, Polymer Carriers), End User - Global Forecast 2025-2030- Product Image
Sale

RNA Therapy Market by Therapeutic Area (Cardiovascular Diseases, Genetic Disorders, Infectious Diseases), Delivery System (Exosomes, Lipid Nanoparticles, Polymer Carriers), End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968964
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The RNA Therapy Market is at a pivotal moment, with rapid technological developments and regulatory changes positioning RNA-based therapeutics as essential tools in precision medicine. Senior decision-makers are now navigating an evolving landscape defined by innovation, new investment opportunities, and shifting global policies.

Market Snapshot: RNA Therapy Market Size and Growth

The RNA Therapy Market grew from USD 2.60 billion in 2024 to USD 3.23 billion in 2025. It is expected to continue growing at a CAGR of 22.96%, reaching USD 9.01 billion by 2030. Market momentum is fueled by advancements in molecular engineering, increased investments in production scalability, and evolving clinical and regulatory pathways. This robust growth reflects a move toward widespread adoption of RNA-based medical solutions alongside enhanced demand in major global regions.

Scope & Segmentation: Overview of Key Market Areas

  • Therapeutic Areas: Cardiovascular diseases; Genetic disorders; Infectious diseases (bacterial and viral infections); Metabolic disorders; Neurological disorders; Oncology (hematological malignancies, solid tumors); Rare diseases (Gaucher disease, neuromuscular disorders, sickle cell disease).
  • Delivery Systems: Exosomes; Lipid nanoparticles; Polymer carriers; Viral vectors.
  • End Users: Biotechnology companies; Hospitals and clinics; Pharmaceutical companies; Research institutes.
  • Regions Covered: Americas (United States, California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Industry Players: Moderna, Inc.; BioNTech SE; Sarepta Therapeutics, Inc.; Alnylam Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; Arrowhead Pharmaceuticals, Inc.; CureVac N.V.; Arcturus Therapeutics Holdings, Inc.; Silence Therapeutics plc; Stoke Therapeutics.

Key Takeaways for Decision-Makers

  • RNA therapies are shifting standard treatment models by enabling gene modulation and personalized intervention strategies across numerous disease segments.
  • Breakthroughs in delivery vehicles such as lipid nanoparticles, exosomes, and polymer-based carriers enhance targeting, reduce immunogenicity, and broaden feasible indications.
  • Shifts in regulatory frameworks are facilitating faster approval cycles for novel RNA modalities, requiring alignment of development and documentation strategies with evolving evidentiary standards.
  • Strategic partnerships between biotech innovators, contract manufacturers, and technology providers are critical for scaling production and maintaining quality assurance at market pace.
  • Integration of digital health technologies and real-time analytics is optimizing trial design, improving dosing precision, and supporting adaptive monitoring of patient outcomes.
  • Emerging investment trends point to increased funding for platform capabilities and manufacturing scalability, underlining the sector’s maturation and long-term growth prospects.

Tariff Impact: Navigating US Policy Shifts

Recent changes to United States tariff policies have led companies to reassess global supply chain approaches. Heightened duties on specialized production materials increased costs, prompting investment in domestic manufacturing and strategic alliances with local suppliers. Tariff adjustments have also sparked dialogue with regulatory agencies, leading to targeted exemptions that help sustain innovation and supply continuity for RNA therapies.

Methodology & Data Sources

This report synthesizes primary insights from expert interviews with scientific, clinical, and regulatory leaders across all regions. Secondary research includes analysis of industry publications, regulatory filings, trial registries, and patent data. Rigorous data triangulation and peer-review processes ensure robust, validated findings and actionable intelligence for strategic planning.

Why This Report Matters

  • Delivers up-to-date, evidence-based insights for executive decision-making on RNA therapy investments and development strategy.
  • Provides detailed segmentation and regional context, informing market entry, expansion, and resource allocation.

Conclusion

RNA-based therapeutics are transforming clinical approaches to complex diseases, supported by technological, regulatory, and supply chain advances. Stakeholders equipped with timely intelligence will be best placed to lead in this evolving market and drive sustainable impact in global healthcare delivery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of lipid nanoparticle formulations optimizing mRNA vaccine delivery and stability for rare diseases
5.2. Growing adoption of GalNAc-conjugated siRNA therapeutics improving targeted gene silencing in liver disorders
5.3. Increased investment in self-amplifying RNA platforms to enhance antigen expression at lower dose levels
5.4. Advances in CRISPR-based RNA editing technologies accelerating in vivo correction of genetic mutations
5.5. Expansion of decentralized manufacturing hubs enabling rapid regional production of RNA-based therapies
5.6. Development of thermostable mRNA vaccine formulations reducing cold chain dependencies in emerging markets
5.7. New collaborations between biopharma and AI firms to accelerate RNA sequence design and delivery vector optimization
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. RNA Therapy Market, by Therapeutic Area
8.1. Introduction
8.2. Cardiovascular Diseases
8.3. Genetic Disorders
8.4. Infectious Diseases
8.4.1. Bacterial Infections
8.4.2. Viral Infections
8.5. Metabolic Disorders
8.6. Neurological Disorders
8.7. Oncology
8.7.1. Hematological Malignancies
8.7.2. Solid Tumors
8.8. Rare Diseases
8.8.1. Gaucher Disease
8.8.2. Neuromuscular Disorders
8.8.3. Sickle Cell Disease
9. RNA Therapy Market, by Delivery System
9.1. Introduction
9.2. Exosomes
9.3. Lipid Nanoparticles
9.4. Polymer Carriers
9.5. Viral Vectors
10. RNA Therapy Market, by End User
10.1. Introduction
10.2. Biotechnology Companies
10.3. Hospitals & Clinics
10.4. Pharmaceutical Companies
10.5. Research Institutes
11. Americas RNA Therapy Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa RNA Therapy Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific RNA Therapy Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Moderna, Inc.
14.3.2. BioNTech SE
14.3.3. Sarepta Therapeutics, Inc.
14.3.4. Alnylam Pharmaceuticals, Inc.
14.3.5. Ionis Pharmaceuticals, Inc.
14.3.6. Arrowhead Pharmaceuticals, Inc.
14.3.7. CureVac N.V.
14.3.8. Arcturus Therapeutics Holdings, Inc.
14.3.9. Silence Therapeutics plc
14.3.10. Stoke Therapeutics
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. RNA THERAPY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RNA THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RNA THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RNA THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RNA THERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RNA THERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS RNA THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS RNA THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES RNA THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES RNA THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. RNA THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. RNA THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. RNA THERAPY MARKET: RESEARCHAI
FIGURE 22. RNA THERAPY MARKET: RESEARCHSTATISTICS
FIGURE 23. RNA THERAPY MARKET: RESEARCHCONTACTS
FIGURE 24. RNA THERAPY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RNA THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RNA THERAPY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RNA THERAPY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RNA THERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RNA THERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RNA THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RNA THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RNA THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RNA THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RNA THERAPY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RNA THERAPY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RNA THERAPY MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RNA THERAPY MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RNA THERAPY MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RNA THERAPY MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RNA THERAPY MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RNA THERAPY MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RNA THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RNA THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RNA THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RNA THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RNA THERAPY MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RNA THERAPY MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RNA THERAPY MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RNA THERAPY MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RNA THERAPY MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RNA THERAPY MARKET SIZE, BY RARE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RNA THERAPY MARKET SIZE, BY GAUCHER DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RNA THERAPY MARKET SIZE, BY GAUCHER DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RNA THERAPY MARKET SIZE, BY NEUROMUSCULAR DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RNA THERAPY MARKET SIZE, BY NEUROMUSCULAR DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RNA THERAPY MARKET SIZE, BY SICKLE CELL DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RNA THERAPY MARKET SIZE, BY SICKLE CELL DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RNA THERAPY MARKET SIZE, BY EXOSOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RNA THERAPY MARKET SIZE, BY EXOSOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RNA THERAPY MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RNA THERAPY MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RNA THERAPY MARKET SIZE, BY POLYMER CARRIERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RNA THERAPY MARKET SIZE, BY POLYMER CARRIERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RNA THERAPY MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RNA THERAPY MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RNA THERAPY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RNA THERAPY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RNA THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RNA THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RNA THERAPY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RNA THERAPY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RNA THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RNA THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS RNA THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS RNA THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES RNA THERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES RNA THERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 93. CANADA RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 94. CANADA RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 95. CANADA RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 96. CANADA RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 97. CANADA RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 98. CANADA RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 99. CANADA RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 100. CANADA RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 101. CANADA RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 102. CANADA RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 103. CANADA RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. CANADA RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. MEXICO RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 106. MEXICO RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 107. MEXICO RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 108. MEXICO RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 109. MEXICO RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 110. MEXICO RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 111. MEXICO RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 112. MEXICO RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 113. MEXICO RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 114. MEXICO RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 115. MEXICO RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. MEXICO RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. GERMANY RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 168. GERMANY RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 169. GERMANY RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 170. GERMANY RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 171. GERMANY RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 172. GERMANY RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 173. GERMANY RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 174. GERMANY RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 175. GERMANY RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 176. GERMANY RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 177. GERMANY RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. GERMANY RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. FRANCE RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 180. FRANCE RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 181. FRANCE RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 182. FRANCE RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 183. FRANCE RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 184. FRANCE RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 185. FRANCE RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 186. FRANCE RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 187. FRANCE RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 188. FRANCE RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 189. FRANCE RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. FRANCE RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. ITALY RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 204. ITALY RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 205. ITALY RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 206. ITALY RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 207. ITALY RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 208. ITALY RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 209. ITALY RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 210. ITALY RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 211. ITALY RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 212. ITALY RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 213. ITALY RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. ITALY RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. SPAIN RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 216. SPAIN RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 217. SPAIN RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 218. SPAIN RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 219. SPAIN RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 220. SPAIN RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 221. SPAIN RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 222. SPAIN RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 223. SPAIN RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 224. SPAIN RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 225. SPAIN RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. SPAIN RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 246. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 248. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 258. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 260. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. DENMARK RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 264. DENMARK RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 265. DENMARK RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 266. DENMARK RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 267. DENMARK RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 268. DENMARK RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 269. DENMARK RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 270. DENMARK RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 271. DENMARK RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 272. DENMARK RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 273. DENMARK RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. DENMARK RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 281. NETHERLANDS RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 282. NETHERLANDS RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 283. NETHERLANDS RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 284. NETHERLANDS RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 285. NETHERLANDS RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. NETHERLANDS RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. QATAR RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 288. QATAR RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 289. QATAR RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 290. QATAR RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 291. QATAR RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 292. QATAR RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 293. QATAR RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 294. QATAR RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 295. QATAR RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 296. QATAR RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 297. QATAR RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. QATAR RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. FINLAND RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 300. FINLAND RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 301. FINLAND RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 302. FINLAND RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 303. FINLAND RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 304. FINLAND RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 305. FINLAND RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 306. FINLAND RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 307. FINLAND RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 308. FINLAND RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 309. FINLAND RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. FINLAND RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 315. SWEDEN RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 316. SWEDEN RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 317. SWEDEN RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 318. SWEDEN RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 319. SWEDEN RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 320. SWEDEN RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 321. SWEDEN RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. SWEDEN RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 325. NIGERIA RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 326. NIGERIA RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 327. NIGERIA RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 328. NIGERIA RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 329. NIGERIA RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 330. NIGERIA RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 331. NIGERIA RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 332. NIGERIA RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 333. NIGERIA RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. NIGERIA RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. EGYPT RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 336. EGYPT RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 337. EGYPT RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 338. EGYPT RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 339. EGYPT RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 340. EGYPT RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 341. EGYPT RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 342. EGYPT RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 343. EGYPT RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 344. EGYPT RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 345. EGYPT RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 346. EGYPT RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 347. TURKEY RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 348. TURKEY RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 349. TURKEY RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 350. TURKEY RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 351. TURKEY RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 352. TURKEY RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 353. TURKEY RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 354. TURKEY RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 355. TURKEY RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 356. TURKEY RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 357. TURKEY RNA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 358. TURKEY RNA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 359. ISRAEL RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 360. ISRAEL RNA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 361. ISRAEL RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 362. ISRAEL RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 363. ISRAEL RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 364. ISRAEL RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 365. ISRAEL RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 366. ISRAEL RNA THERAPY MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 367. ISRAEL RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 368. ISRAEL RNA THERAPY MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 369. ISRAEL RNA THERAPY MARKET SIZE, BY END USER,

Samples

Loading
LOADING...

Companies Mentioned

  • Moderna, Inc.
  • BioNTech SE
  • Sarepta Therapeutics, Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Ionis Pharmaceuticals, Inc.
  • Arrowhead Pharmaceuticals, Inc.
  • CureVac N.V.
  • Arcturus Therapeutics Holdings, Inc.
  • Silence Therapeutics plc
  • Stoke Therapeutics

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.23 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.01 Billion
Compound Annual Growth Rate22.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Small Nucleic Acid Therapies Market by Therapy Type (Antisense Oligonucleotides, Aptamers, miRNA Therapeutics), Route of Administration (Oral Route, Parenteral Route), Delivery Mechanism, Therapeutic Application, End User - Global Forecast 2025-2030 - Product Image

Small Nucleic Acid Therapies Market by Therapy Type (Antisense Oligonucleotides, Aptamers, miRNA Therapeutics), Route of Administration (Oral Route, Parenteral Route), Delivery Mechanism, Therapeutic Application, End User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
mRNA Therapeutics Market by Technology Platform (Lipid Nanoparticles, Polymer Based, Viral Vectors), Therapeutic Application (Cardiovascular, Infectious Diseases, Oncology), Delivery Method - Global Forecast 2025-2030 - Product Image

mRNA Therapeutics Market by Technology Platform (Lipid Nanoparticles, Polymer Based, Viral Vectors), Therapeutic Application (Cardiovascular, Infectious Diseases, Oncology), Delivery Method - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
RNA-based Therapeutics - Global Strategic Business Report - Product Image

RNA-based Therapeutics - Global Strategic Business Report

  • Report
  • 274 Pages
  • Global
From
SiRNA Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

SiRNA Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 87 Pages
  • Global
From
RNA Therapy Clinical Trials - Global Strategic Business Report - Product Image

RNA Therapy Clinical Trials - Global Strategic Business Report

  • Report
  • 244 Pages
  • Global
From

About the RNA Therapy Market

RNA therapy is a form of gene therapy that uses RNA molecules to treat or prevent diseases. It is a type of genomics-based therapy that works by introducing genetic material into cells to modify their behavior. RNA therapy can be used to treat a variety of diseases, including cancer, neurological disorders, and infectious diseases. It has the potential to be used to treat genetic disorders, as well as to modify the expression of genes in order to improve the effectiveness of existing treatments. RNA therapy works by introducing genetic material into cells, which can then be used to modify the expression of genes. This can be done by introducing a gene that produces a therapeutic protein, or by introducing a gene that silences a gene that is causing a disease. RNA therapy can also be used to modify the expression of existing genes, which can be used to improve the effectiveness of existing treatments. RNA therapy is an emerging field of genomics-based therapy, and is being explored by a number of companies. Examples of companies in the RNA therapy market include Moderna, BioNTech, and Arcturus Therapeutics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.